Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 6, 2024

Self-reported smoking status was assessed at each consecutive visit and used to determine smoking cessation after each interim ASCVD event (myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, stroke/transient ischemic attack, peripheral artery disease).

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Outpatient Peripheral Arterial Disease Cardiovascular Disease 45

DAIC

SEPTEMBER 24, 2024

Our innovative approach to fibrinolytic therapy has the potential to transform the treatment landscape for life-threatening thrombotic conditions, offering patients a faster, safer, and more effective reperfusion option. “Our “We are thrilled to achieve this important milestone with the FDA clearance for our first U.S. Wallace, MSc.

Physiology 52

Physiology Myocardial Infarction Heart Attack Heart attacks 52

Cardiology Update

JUNE 24, 2024

This comprehensive approach allows for precise differentiation between various cardiomyopathies, myocarditis, and myocardial infarction. This global collaboration of experts provides a platform for innovation, technical development, and dissemination of research findings.

Myocardial Infarction 52

Myocardial Infarction Anatomy Cardiovascular Imaging Research 52

SoftCath

OCTOBER 31, 2021

So, let’s unwind how the innovations in cath lab software are reshaping the method of cardiovascular care post-Covid-19. All of this resulted in the need for better and innovative cardiac care strategies that ensure better patient engagement and trust in digital medical infrastructure.

COVID-19 52

COVID-19 Innovation Cardiac Rehabilitation Cardiovascular Disease 52

Dr. S. Venkatesan MD

APRIL 22, 2024

This typically occurs after an inferior posterior myocardial infarction, drug-induced CHB. Now we realise it is an additional metallic luggage in an already strained heart, Temporary-PPM the oxymoronic innovation is perfect option in this setting.

Pacemaker 40

Pacemaker Aortic valve TAVR Myocardial Infarction 40

DAIC

MAY 14, 2024

The impact of this narrowing can ultimately result in angina (chest pain), which has been shown to double the risk of major cardiovascular events,1 as well as myocardial infarction ( heart attack ) or even death.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

MARCH 31, 2025

mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. Budoff, M.D.,

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack 52

DAIC

JUNE 12, 2024

RWMAs can be an independent indicator of adverse cardiovascular events and death in patients with cardiovascular diseases like myocardial infarction (MI) and congenital heart disease. Automated machine learning-based assessment of RWMA has the potential to improve the efficiency of all readers. “An

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

DAIC

MAY 8, 2024

Journal of Vascular Surgery Cases, Innovations and Techniques, vol. 2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. For more information: www.heartflow.com References 1 Krievins, Dainis K.,

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

DECEMBER 14, 2023

The NCSI participating hospitals agreed to treat patients who presented with acute myocardial infarction and cardiogenic shock using a standard protocol, which involved rapid initiation of mechanical circulatory support (MCS) with an Impella 2.5 Division Head of Cardiology at Henry Ford Health.

Cardiogenic Shock 105

Cardiogenic Shock Heart Attack Heart attacks Myocardial Infarction 105

DAIC

MARCH 28, 2024

Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." patients, were presented as a late-breaker at the 2024 AF Symposium.

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

DECEMBER 20, 2023

associate professor of biomedical research and translational medicine and scientific operations director at MMRI , recently published an innovative manuscript titled, Biomimetic Nanomaterials for the Immunomodulation of the Cardiosplenic Axis Post-Myocardial Infarction. McCarthy, Ph.D.

Heart Attack 115

Heart Attack Heart attacks Myocardial Infarction Research 115

Cardiometabolic Health Congress

APRIL 12, 2024

Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovascular disease (CVD). Heart disease remains the leading cause of death for men and women. 80% of heart attacks and strokes linked to CVD are preventable with optimal risk factor management.

Myocardial Infarction 64

Myocardial Infarction Cardiovascular Disease Heart Attack Heart attacks 64

DAIC

MARCH 31, 2025

mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. Budoff, M.D.,

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack 52

DAIC

MAY 29, 2024

We are progressing development of AZD0780 as an innovative, convenient oral option for patients who are currently unable to meet their LDL-C targets with statins alone to reduce their risk of CV events.” Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 2016;76(12):1175-90.

Cholesterol 52

Cholesterol Cardiovascular Disease Atherosclerosis Myocardial Infarction 52

Stroke: Vascular and Interventional Neurology

AUGUST 4, 2024

Research was funded by Germany's Federal Joint Committee Innovation Fund (funding reference number 01VSF19016). Secondary outcome events were inhospital stroke, major stroke or death, death, myocardial infarction, and major adverse cardiovascular events. A total of 119800 patients remained in the analysis.

Hospital 40

Hospital Outcomes Myocardial Infarction Stenosis 40

Open Heart

JULY 10, 2023

The risk of AF was estimated using the FIND-AF (Future Innovations in Novel Detection of Atrial Fibrillation) risk score. to 8.34; 4.27), myocardial infarction (69.6; We calculated cumulative incidence rates and fit Fine and Gray’s models at 1, 5 and 10 years for nine diseases and death adjusting for competing risks.

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

Dr. S. Venkatesan MD

NOVEMBER 25, 2023

cit0923_ft_zoll-1 Download Final message Innovation and experimentation is must be allowed as liberally as possible. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction. (Oxygen in liquid from might behave differently as in this study ?)

STEMI 40

STEMI Myocardial Infarction Download Document 40

Wellnest

JULY 19, 2023

When one of these arteries becomes completely blocked by a blood clot, it results in a heart attack, also known as MI (Myocardial infarction). When a person experiences a heart attack or myocardial infarction, they may feel chest pain and other symptoms in different parts of their body.

Heart Attack 52

Heart Attack Heart attacks Blood Pressure Myocardial Infarction 52

Cardiometabolic Health Congress

DECEMBER 5, 2024

As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. The NUDGE-FLU trial revealed cardiovascular-focused messaging increased flu vaccination rates in myocardial infarction patients. Watch AI-ECHO results.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103